Literature DB >> 24154801

Unclassified cardiomyopathies in neuromuscular disorders.

Josef Finsterer1, Claudia Stöllberger.   

Abstract

OBJECTIVES: Unclassified cardiomyopathies (CMPs) include left ventricular hypertrabeculation or noncompaction (LVHT) and Takotsubo syndrome (TTS). Unclassified CMPs are frequently associated with noncardiac disease, including neuromuscular disorders (NMDs). This review aims at summarizing and discussing recent findings concerning the association of NMDs with unclassified CMPs.
METHODS: Literature search using the database PubMed from 1966 to June 2013 was performed.
RESULTS: LVHT has been described in association with dystrophinopathies, myotonic dystrophies, zaspopathies, laminopathies, dystrobrevinopathies, oculopharyngeal muscular dystrophy, tropomyosin-1 mutations, multiminicore disease, Danon disease, mitochondrial disorders, myoadenylate deaminase deficiency, Pompe's disease, glycogen storage disease-IV, fatty acid oxidation disorder, Barth syndrome, ryanodine receptor mutation, inclusion body myopathy, dystrophic epidermolysis bullosa, Charcot-Marie-Tooth neuropathy, hereditary cobolamine deficiency, beta-thalassemia, poliomyelitis, and Friedreich ataxia. Takotsubo syndrome has been described in association with myasthenia gravis, amyotrophic lateral sclerosis, Guillain-Barre syndrome, rhabdomyolysis, mitochondrial disorder, hypokalemia-related myopathy, syndrome malin, hereditary sensorimotor neuropathy, Beals syndrome, polymyalgia rheumatica, and unclassified myopathy. It is important for treating physicians to know about these associations because treatment and outcome of LVHT, including artificial ventilation, are determined by the presence or absence of an NMD. There are also indications that LVHT in NMDs favors the development of TTS.
CONCLUSIONS: LVHT and TTS may be associated with NMDs. The pathogenetic link between unclassified CMPs and NMDs remains elusive. Outcome of LVHT and treatment of TTS are additionally determined by the presence or absence of an NMD.

Entities:  

Mesh:

Year:  2013        PMID: 24154801     DOI: 10.1007/s10354-013-0243-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  88 in total

1.  Poliomyelitis and left ventricular hypertrabeculation (noncompaction).

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Int J Cardiol       Date:  2011-11-10       Impact factor: 4.164

2.  Biventricular noncompaction presenting with stroke.

Authors:  Vecih Oduncu; Taylan Akgun; Ayhan Erkol; Bülent Mutlu
Journal:  Eur J Cardiothorac Surg       Date:  2008-02-06       Impact factor: 4.191

3.  Loss of function of hNav1.5 by a ZASP1 mutation associated with intraventricular conduction disturbances in left ventricular noncompaction.

Authors:  Yutao Xi; Tomohiko Ai; Enno De Lange; Zhaohui Li; Geru Wu; Luca Brunelli; W Buck Kyle; Isik Turker; Jie Cheng; Michael J Ackerman; Akinori Kimura; James N Weiss; Zhilin Qu; Jeffrey J Kim; Georgine Faulkner; Matteo Vatta
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-28

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  [Transient ventricular dysfunction (Takotsubo cardiomyopathy)].

Authors:  José Marconi Almeida de Sousa; Marcos Knobel; Gustavo Buchelle; José Augusto M de Sousa; Cláudio H Fisher; Daniel Born; Nelson Akamine; Elias Knobel
Journal:  Arq Bras Cardiol       Date:  2005-05-02       Impact factor: 2.000

6.  Stress-induced cardiomyopathy caused by heat stroke.

Authors:  Wei-Ta Chen; Cheng-Hsin Lin; Ming-Hsiung Hsieh; Chun-Yao Huang; Jong-Shiuan Yeh
Journal:  Ann Emerg Med       Date:  2011-12-07       Impact factor: 5.721

7.  Barth syndrome in a female patient.

Authors:  Laure Cosson; Annick Toutain; Gilles Simard; Willem Kulik; Gabor Matyas; Agnès Guichet; Hélène Blasco; Zoha Maakaroun-Vermesse; Marie-Catherine Vaillant; Cédric Le Caignec; Alain Chantepie; François Labarthe
Journal:  Mol Genet Metab       Date:  2012-01-24       Impact factor: 4.797

8.  Consequences of misdiagnosing mitochondrial disorder.

Authors:  Josef Finsterer
Journal:  Int J Neurosci       Date:  2006-08       Impact factor: 2.292

9.  Left ventricular hypertrabeculation/noncompaction in hereditary inclusion body myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger; Romana Höftberger
Journal:  Int J Cardiol       Date:  2009-11-08       Impact factor: 4.164

10.  Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.

Authors:  Manuel Hermida-Prieto; Lorenzo Monserrat; Alfonso Castro-Beiras; Rafael Laredo; Rafaela Soler; Jesus Peteiro; Esther Rodríguez; Beatriz Bouzas; Nemesio Alvarez; Javier Muñiz; Marisa Crespo-Leiro
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  4 in total

Review 1.  Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors.

Authors:  Josef Finsterer; Claudia Stöllberger; Jeffrey A Towbin
Journal:  Nat Rev Cardiol       Date:  2017-01-12       Impact factor: 32.419

2.  Mutations in genes associated with either myopathy or noncompaction.

Authors:  J Finsterer; C Stollberger
Journal:  Herz       Date:  2018-04-20       Impact factor: 1.443

Review 3.  Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach.

Authors:  Stacey Reynolds
Journal:  J Multidiscip Healthc       Date:  2015-07-29

4.  The Feline Cardiomyopathies: 1. General concepts.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.